iRadimed Corporation

IRMD Healthcare Medical Devices

iRadimed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $83.8 million, up 14.4% from fiscal 2024.

Revenue
+14.2%
EPS
+15.9%
Free cash flow
+18.6%

Quarter to September 2026, against a year earlier

86.17 0.63 +0.74%
Market cap
$1.1B
P/E
45.6×
Fwd P/E
39.6×
Dividend yield
0.89%
F-score
6/9
Altman Z
55.62
Beneish M
−2.55
Dividend safety
40/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
6 5 6 6

+8 more TTM periods

ROE
23.42% 23.52% 25.04% 24.78%
ROA
20.34% 20.82% 21.85% 21.71%
ROIC
41.79% 40.36% 41.46% 37.60%
Return on Tangible Assets
22.51% 22.65% 23.96% 23.69%
Average Days of Receivables
55.87 55.77 56.75 59.52
Free Cash Flow per Share
2.00 1.92 1.88 1.30
Free Cash Flow
25.61 24.55 23.97 16.53
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026